11 C
New York
Friday, May 10, 2024

Morgan Stanley Remains Positive On Stryker Corporation

Courtesy of Benzinga.

Related SYK
Morgan Stanley Has Critical Questions For Stryker Corporation Going Into Investor Day
Top 4 NYSE Stocks In The Medical Appliances & Equipment Industry With The Highest Revenue

In a report published Thursday, Morgan Stanley analyst David R. Lewis reiterated an Overweight rating and $91.00 price target on Stryker Corporation (NYSE: SYK).

In the report, Morgan Stanley noted, “We approached the analyst day looking for a commitment to leverage and improving M&A returns and left mostly satisfied. There was no commentary on SNN given UK takeover rules, but we remain unconvinced SNN can drive appropriate returns for shareholders at this time.”

Stryker Corporation closed on Wednesday at $83.94.

Latest Ratings for SYK

Date Firm Action From To
Aug 2014 Needham Upgrades Buy
Jul 2014 Citigroup Maintains Neutral
Jul 2014 Barclays Maintains Equal-weight

View More Analyst Ratings for SYK
View the Latest Analyst Ratings

Posted-In: David R. Lewis Morgan StanleyAnalyst Color Reiteration Analyst Ratings

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,239FansLike
396,312FollowersFollow
2,300SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x